Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...
FitLife Brands, Inc. (PNK:FTLF) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 FitLife Brands, Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.23. Operator: Good day, and welcome to the FitLife Brands’ ...
Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results
Summit State Bank (the "Bank") (Nasdaq: SSBI) today reported that it has revised its fourth quarter and full year 2024 financial results from those ...
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer - - Positive Preliminary Phase 1b/2 Data ...